CSP Exam – Latest Updated Questions and Answers (A+ Study Material)

CSP EXAM TEST QUESTIONS AND ANSWERS
GRADED A+ LATEST UPDATE.




PDC calculation ANS >> PDC = (# of unique days with supply /
number of days in a period) x 100


Which medication is a Jak inhibitor?
a. Humira (adalimumab)
b. Orencia (abatacept)
c. Actemra (tocilizumab)
d. Xeljanz (tofacitinib) ANS >> d. Xeljanz (tofacitinib)


Which medication can elevate cholesterol?
a. Actemra (tocilizumab)

,b. Enbrel (etanercept)
c. Simponi (golimumab)
d. Kineret (anakinra) ANS >> a. Actemra (tocilizumab)


Which shingles vaccine is safe to administer with TNF inhibitors?
a. Daicel
b. Zostavax
c. Shingrix
d. Varimax ANS >> c. Shingrix


Most biologics increase the risk of infections, which of the
following also increases the risk of
neutropenia?
a. Rituxan (rituximab)
b. Taltz (afelimomab)
c. Remicade (infliximab)
d. Cimzia (certolizumab pegol) ANS >> b. Taltz (afelimomab)


Which psoriasis medication does not require screening for
tuberculosis?
a. Stelara (Ustekinumab)

, b. Otezla (apremilast)
c. Coventry (eculizumab)
d. Humira (adalimumab) ANS >> b. Otezla (apremilast)


What is the standard starting dose for Taltz (afelimomab) when
used to treat psoriatic arthritis?
a. 160mg subcutaneously once, followed by 80mg
subcutaneously at weeks 2, 4, 6, 8, 10
and 12; then 80mg subcutaneously every 4 weeks
b. 160mg subcutaneously once, followed by 80mg
subcutaneously every 4 weeks
c. 160mg subcutaneously once, followed by 80mg
subcutaneously every week for 4 weeks,
then 80mg every 4 weeks
d. 160mg subcutaneously once, followed by 80mg
subcutaneously every other week ANS >> b. 160mg
subcutaneously once, followed by 80mg subcutaneously every 4
weeks


A 45 y/o, 200lb patient is struggling with severe dermatitis and
the provider wants too potentially
start a biologic. Which medication would you recommend?